Introduction
A variety of studies has suggested that neurotrophins such as brain-derived neurotrophic factor (BDNF) facilitate survival and growth of neurones [1±3] . In the retina, BDNF and its high (TrkB) and low (p75) af®nity receptors are primarily associated with ganglion cells [4, 5] . Damage to the ganglion cells, elicited by optic nerve crush, for example, is reduced by intravitreal injections of BDNF, although the neuroprotection is transient [6] .
Ischaemia to the retina can be induced by raising the intraocular pressure above the systolic blood pressure, and damage to the inner part of the retina (ganglion cells and a subset of amacrine cells) occurs following various periods of reperfusion [7, 8] . In a previous study, it was noticed that the BDNF immunoreactivity in the ganglion cells appeared to be enhanced 2 h after an ischaemic insult of 60 min, but was drastically reduced when analysed 48 h after reperfusion [5] . This suggested that an initial insult to the ganglion cells may cause an up-regulation of BDNF and so provide an endogenous mechanism to counteract the insult. The aim of the present experiments was to substantiate this possibility by investigating whether the BDNF mRNA and/or protein in the ganglion cells is up-regulated following injury of the cells with NMDA.
Ganglion and certain amacrine cells (e.g. cholinergic amacrine cells) contain NMDA receptors [9] , and following intravitreal injection of NMDA these cells are destroyed with time, the rate being dependent on the amount of NMDA injected [10] . This provides a precise way of inducing an insult to speci®c cell-types in the retina, which include the ganglion cells. In this study a known amount of NMDA was injected into one eye of the rat and the retina analysed for BDNF immunoreactivity and BDNF mRNA after de®ned periods of time. ChAT (choline acetyltransferase) immunoreactivity of the retina was also analysed to ascertain the effect of NMDA on a protein associated with cholinergic amacrine cells.
Materials and Methods
All investigations involving the use of animals conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Wistar rats (150±200 g) kept under a 12:12 h light:dark cycle were anaesthetized with Hypnorm (Janssen: 0.3 ml/ kg, i.p.) and diazepam (0.25 mg/kg, i.p.). After anaesthesia 2 ìl NMDA 20 mM (Cambridge Research Biochemicals) in NaCl 0.9% was injected into the left eye. The right eye acted as the control and was injected with 2 ìl NaCl 0.9%. After 2 h (n 8) or 48 h (n 6) rats were deeply anaesthetized with pentobarbital and transcardially perfused ®rst with physiological saline and then with 2% paraformaldehyde/phosphate buffer solution. Eyes were then enucleated, the retinas dissected and ®xed for a further 3 h in 2% paraformaldehyde phosphate buffer before cryopreservation in 30% sucrose± phosphate buffer. Frozen 10 ìm sections of the ®xed tissues were produced on chrome±alum±gelatin slides and kept at À208C.
For immunohistochemistry, slides were ®rst thawed and twice rinsed in PBS/Triton buffer (0.1 M phosphate buffer saline containing 0.25% Triton X-100) for about 10 min. The sections were then incubated overnight in a humidity chamber at 48C, in one of the following antibodies diluted in PBS/ Triton buffer and containing 1% bovine serum albumin: rabbit anti-BDNF (diluted 1:200; Santa Cruz 546), or rat monoclonal anti-ChAT (Boehringer Mannheim Biochemica 770981, 1 ìg/ml). After rinsing in PBS/Triton buffer the retinae were incubated in goat anti-rabbit IgG conjugated with¯uor-escein isothiocyanate (diluted 1:100, Sigma) for the anti-BDNF sections and in rabbit anti-rat IgG FITC conjugate (diluted 1:200; Sigma, F-6258) for the anti-ChAT and processed as described [5, 8] before the sections were examined with a microscope equipped with epi¯uorescence optics.
For the semi-quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) experiments one eye of an anaesthetized rat was injected with 40 nmol NMDA contained in 5 ìl sterile 0.1 M phosphate buffer. Control rats received only phosphate buffer and the contralateral remained uninjected. The rats were then allowed to recover for 2 or 4 h, perfused as described above and the retinas were excised into 400ìl TriReagent (SIGMA). Total RNA was isolated as per manufacturers instructions and ®rst strand cDNA was synthesized from 2 ìg RNA using 200 U M-MLV reverse transcriptase (Promega), 24 U RNasin, 5 ng oligo (dT) 30 and 0.6 mM each deoxynucleotide triphosphate in a reaction volume of 15 ìl containing reaction buffer (Promega). Controls contained no reverse transcriptase. After 1 h at 428C the solution was diluted with 135 ìl H 2 O and 10 ìl aliquots were stored at À208C.
Ampli®cation was performed in a reaction mix (total volume 50 ìl) containing a cDNA aliquot, PCR buffer (10 mM Tris±HCl, pH 8.3, 50 mM KCl), MgCl 2 (4 mM for Thy-1, 5 mM for BDNF and rhodopsin), 200 ìM each deoxynucleotide triphosphate, 4 ng/ìl of both the sense and antisense primers and 2.5 U AmpliTaq Gold. Primer pairs were 59-CGCTTTATCAAGGTCCTTACTC-39 and 59-GCGTTTTGAGATATTTGAAGGT-39 for Thy-1, 59-CAGTGTTCATGTGGGATTGACT-39 and 59-ATGATTGGGTTGTAGATGGAGG-39 for rhodopsin [11] and 59-ATGACCATCCTTTTCCT-TACTATGGT-39 and 59-TCTTCCCCTTTTAA-TGGTCAGTGTAC-39 for BDNF [12] 
The PCR products in 10 ìl aliquots of the reaction mixes were then separated by 1.5% agarose gel electrophoresis and visualized using ethidium bromide. The abundance of each band was determined by densitometry analysis of polaroid photographs using SigmaScan (Jandel Scienti®c). Data for each retina were expressed as ratios (BDNF:rhodopsin, BDNF:Thy-1 and Thy-1:rhodopsin) and the percentage effect of the injection was determined by comparison of the injected eye with the control eye. Statistical signi®cance was determined using Student's paired t-test.
Results
Immunohistochemistry: Injection of 2 ìl saline into the vitreous humour of the rat eye caused no detectable change in either the BDNF or choline acetyltransferase (ChAT) immunoreactivities in the retina when examined between 2 h and 2 days later (results not shown). BDNF immunoreactivity is primarily associated with cells in the ganglion cell layer (Fig. 1) while ChAT immunoreactivity is BDNF immunoreactivity is associated mainly with some cell bodies in the ganglion cell layer (A,C). Two hours following an intravitreal injection of NMDA, the BDNF immunoreactivity associated with the cells in the ganglion cell layer appeared to be enhanced (B). This was, however not the case 48 h after NMDA treatment (D). In this case the BDNF immunoreactivity associated with the cells in the ganglion cell layer was almost obliterated. Bars 50 ìm. associated with two layers of processes in the inner plexiform layer and cell bodies on each side of the processes (Fig. 2) . However, 48 h following an injection of NMDA (2 ìl of 20 mM) into the vitreous humour a drastic reduction of retinal BDNF and ChAT immunoreactivities occurred ( Fig. 1D;  Fig. 2D ). The ChAT immunoreactivity was also slightly reduced 2 h after NMDA treatment (Fig. 2B) but this was not the case for BDNF immunoreactivity (Fig. 1B) . In this instance ganglion cell retinal BDNF-immunoreactivity was enhanced (Fig. 1B) compared with the saline treated control retina (Fig. 1A) .
Semiquantitative RT-PCR: The effect of NMDA on the expression of BDNF mRNA in the rat retina is shown in Fig. 3 . The expression of retinal BDNF mRNA 2 h after NMDA injection into the vitreous humour of one eye is signi®cantly enhanced, relative to the contralateral control retina (Fig. 3, lanes 1 and  2) . In contrast, there is little difference in expression following vehicle injection compared with the untreated eye (Fig. 3, lanes 7 and 8) . Moreover, the expression of Thy-1 and rhodopsin mRNA appears unaffected by the NMDA injection. Table 1 summarizes the combined data from a number of separate retinas. Clearly, 2 h after injection of NMDA a large increase in BDNF mRNA expression in comparison to the control retina occurred, but this was not the case for Thy-1 and rhodopsin mRNA expression. This increase is no longer evident after 4 h. A comparison of Thy-1 and rhodopsin mRNA levels showed no change occurring after injection of either vehicle or 2 h after NMDA treatment. However, a signi®cant decrease in Thy-1 mRNA had occurred 4 h after treatment with NMDA.
Discussion
Injection of NMDA into the vitreous humour causes destruction of ganglion cells [10] and cholinergic amacrine cells [8] . This is supported in the present studies, where 48 h following injection of 2 ìl 20 mM NMDA into the vitreous humour ChAT and BDNF immunoreactivities were practically obliterated and a loss of Thy-1 mRNA occurred. Thy-1 is speci®cally associated with ganglion cells [13, 14] , and it has been demonstrated that Thy-1 mRNA relative to opsin mRNA (in photoreceptors) is reduced following NMDA toxicity to the retina [11] .
Following an insult to a neurone one would expect a cell to respond with a defensive mechanism, and if this could not be sustained then the cell would die. Evidence is provided in this study to show that BDNF in the ganglion cells is upregulated immediately after NMDA toxicity, supporting the view that this neurotrophin has a role as an endogenous neuroprotector. It is shown here that 2 h after an insult with NMDA, both BDNF mRNA and protein are up-regulated. At the same time the ChAT immunoreactivity associated with a subset of amacrine cells is reduced, showing that not all proteins are up-regulated. The BDNF data are thus consistent with the observation made previously which showed that BDNF immunoreactivity appeared to be enhanced in the ganglion cells 2 h after an ischaemic insult [5] . How would up-regulation of endogenous BDNF possibly counteract the effect of an insult? NMDA causes death of ganglion cells by apoptosis [15] , and there is evidence to show that BDNF delays apoptotic cell death [16] . Another possibility is that BDNF counteracts the effects of damaging reactive oxygen species [17] generated during NMDA-induced toxicity [18] .
BDNF itself possesses antioxidant properties [17] , although some studies have suggested that BDNF can stimulate the production of reactive oxygen species [19] . It has also been reported that BDNF stimulates free intracellular calcium concentrations within cells [20] , which does not support its role as a neuroprotectant.
Conclusion
These results show that BDNF is immediately upregulated in the ganglion cells as a response to an insult to the neurones. Since many studies have shown BDNF to enhance the survival of neurones it is suggested that delivery of BDNF to the retina immediately after an impact to the ganglion cells, as occurs in traumatic optic injury [21] , may protect the ganglion cells from irreversible cell death.
